Astrana Health (NASDAQ:ASTH) PT Lowered to $45.00 at Stifel Nicolaus

Astrana Health (NASDAQ:ASTHGet Free Report) had its price target reduced by equities researchers at Stifel Nicolaus from $50.00 to $45.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 27.33% from the stock’s current price.

A number of other analysts have also issued reports on the company. Truist Financial raised their price target on Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a research note on Friday, March 1st. Jefferies Financial Group initiated coverage on shares of Astrana Health in a research report on Monday, February 26th. They issued a “buy” rating and a $50.00 target price on the stock.

Get Our Latest Research Report on Astrana Health

Astrana Health Stock Down 6.8 %

Shares of NASDAQ:ASTH traded down $2.59 during trading on Wednesday, reaching $35.34. The stock had a trading volume of 7,238 shares, compared to its average volume of 152,303. The company has a current ratio of 2.11, a quick ratio of 2.11 and a debt-to-equity ratio of 0.42. The firm has a market cap of $1.98 billion, a PE ratio of 26.77, a P/E/G ratio of 1.20 and a beta of 1.12. The firm’s fifty day moving average is $40.36. Astrana Health has a fifty-two week low of $28.86 and a fifty-two week high of $45.71.

Astrana Health (NASDAQ:ASTHGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The business had revenue of $404.36 million during the quarter, compared to analyst estimates of $413.84 million. During the same quarter last year, the firm posted $0.42 earnings per share. The company’s revenue was up 19.9% on a year-over-year basis. As a group, equities analysts forecast that Astrana Health will post 1.65 EPS for the current year.

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.